Страна: Австралия
Язык: английский
Источник: APVMA (Australian Pesticides and Veterinary Medicines Authority)
ORBIFLOXACIN
INTERVET AUSTRALIA PTY LIMITED
orbifloxacin(6.25mg/Tb)
ORAL TABLET
ORBIFLOXACIN ANTIBIOTIC Active 6.25 mg/Tb
100x6.25mg; Tablets
VM - Veterinary Medicine
INTERVET AUSTRALIA
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
ANTIBIOTIC & RELATED
ACINETOBACTER SPP. | ENTEROBACTER SPP. | ENTEROCOCCUS FAECALIS | ESCHERICHIA COLI (E. COLI) | KLEBSIELLA PNEUMONIAE | PASTEURELLA MULTOCIDA | PROTEUS MIRABILIS | PSEUDOMONAS SPP. | STAPHYLOCOCCUS INTERMEDIUS | STREPTOCOCCUS - HEMOLYTIC GROUP G | DEEP PYODERMAS | FOWL CHOLERA | INCLUDING B-LACTAMASE PRODUCIN | INCLUDING SECONDARY INVADERS | SEBORRHOEIC DERMATITIS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [ACINETOBACTER SPP., ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA PNEUMONIAE, PASTEURELLA MULTOCIDA, PSEUDOMONAS SPP., STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS - HEMOLYTIC GROUP G]; DOG: [ACINETOBACTER SPP., ENTEROBACTER SPP., ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), KLEBSIELLA PNEUMONIAE, PASTEURELLA MULTOCIDA, PROTEUS MIRABILIS, PSEUDOMONAS SPP., STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS - HEMOLYTIC GROUP G]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ACINETOBACTER SPP., ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA PNEUMONIAE, PASTEURELLA MULTOCIDA, PSEUDOMONAS SPP., STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS - HEMOLYTIC GROUP G]; DOG: [ACINETOBACTER SPP., ENTEROBACTER SPP., ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), KLEBSIELLA PNEUMONIAE, PASTEURELLA MULTOCIDA, PROTEUS MIRABILIS, PSEUDOMONAS SPP., STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS - HEMOLYTIC GROUP G]; For the treatment of diseases caused by orbifloxacin- sensitive bacteria in dogs and cats.Not for use in food producing species. DO NOT use in pregnant or lactating animals. DO NOT use in juvenile dogs during the rapid growth phase.
Registered
2023-07-01
_________________________________________________________________________ 50764_1099c.doc 25.11.99 Page 1 of 8 ORBAX TABLETS 6.25MG – PRIMARY PACK CARTON - FRONT PANEL _________________________________________________________________________________ PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY ORBAX 6.25 MG TABLETS FOR DOGS AND CATS ACTIVE CONSTITUENT: ORBIFLOXACIN 6.25 mg For the treatment of diseases caused by orbifloxacin-sensitive bacteria in dogs and cats. 100 TABLETS SCHERING-PLOUGH ANIMAL HEALTH Info PEST ✔ Verified _________________________________________________________________________ 50764_1099c.doc 25.11.99 Page 2 of 8 ORBAX TABLETS 6.25MG – PRIMARY PACK CARTON - OTHER PANELS _________________________________________________________________________________ READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT INDICATIONS DOGS AND CATS : For treatment of skin and associated soft tissue infections (wounds and abscesses) caused by susceptible strains of _Staphylococcus intermedius, E. coli, Enterobacter _ spp _., Pasteurella_ _multocida, Klebsiella pneumoniae, Pseudomonas _ spp _., Acinetobacter _ spp _., and Streptococcus_ - hemolytic group G. DOGS : For treatment of urinary tract infections caused by susceptible strains of _E. coli, Proteus_ _mirabilis, Staphylococcus intermedius _ and _Enterococcus faecalis_ . DIRECTIONS FOR USE: NOT FOR USE IN FOOD PRODUCING SPECIES. CONTRA-INDICATIONS AND PRECAUTIONS DO NOT USE IN PREGNANT OR LACTATING ANIMALS. DO NOT USE IN JUVENILE DOGS DURING THE RAPID GROWTH PHASE. ORBAX Tablets are contra-indicated in juvenile dogs during the rapid growth phase (between 2 and 8 months of age in small and medium breeds, up to 12 months in large breeds and up to 18 months in giant breeds. DOSAGE AND ADMINISTRATION FOR ORAL USE ONLY. The recommended dosage is 2.5 mg/kg bodyweight administered once daily. See enclosed leaflet for further information. FOR FURTHER INFORMATION CONTACT SCHERING-PLOUGH CUSTOMER SERVICE ON 1 800 2 Прочитать полный документ
PRODUCT NAME: ORBAX TABLETS MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: AUGUST, 2009 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Orbifloxacin is a fluoroquinolone antibiotic. TRADE NAME: ORBAX TABLETS OTHER NAMES: This MSDS is intended for three sizes of tablet for different sized dogs and cats. RECOMMENDED USE: For the treatment of diseases caused by orbifloxacin-sensitive bacteria in dogs and cats. APVMA NO: 510632; 510649; 510656 CREATION DATE: August, 2009 THIS VERSION ISSUED: August, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S2, S22, S24/25. Keep out of reach of children. Do not breathe dust. Avoid contact with skin and eyes. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: White tablets. ODOUR: Mild odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. This is an antibiotic preparation. Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation. This is a physiologically active product and so contact should be minimised, especially if the user is taking a form of medication, as interactions can sometimes give unexpected and undesired results. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN C Прочитать полный документ